Molecular determinants for enzalutamide-induced transcription in prostate cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular determinants for enzalutamide-induced transcription in prostate cancer
Authors
Keywords
-
Journal
NUCLEIC ACIDS RESEARCH
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-09-05
DOI
10.1093/nar/gkz790
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
- (2018) Xiangming Ji et al. ONCOGENE
- Nucleolar TRF2 attenuated nucleolus stress-induced HCC cell-cycle arrest by altering rRNA synthesis
- (2018) Fuwen Yuan et al. Cell Death & Disease
- Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth
- (2017) Jacob Kach et al. MOLECULAR CANCER THERAPEUTICS
- LAMPs: Shedding light on cancer biology
- (2017) Federica Alessandrini et al. SEMINARS IN ONCOLOGY
- The Mediator Complex: At the Nexus of RNA Polymerase II Transcription
- (2017) Célia Jeronimo et al. TRENDS IN CELL BIOLOGY
- Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer
- (2017) Neel Shah et al. eLife
- Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth
- (2016) Shira L Cramer et al. NATURE MEDICINE
- The role of GATA2 in lethal prostate cancer aggressiveness
- (2016) Veronica Rodriguez-Bravo et al. Nature Reviews Urology
- Novel and next-generation androgen receptor–directed therapies for prostate cancer: Beyond abiraterone and enzalutamide
- (2016) Richard M. Bambury et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer
- (2016) Christopher Foley et al. Hormones & Cancer
- A Targetable GATA2-IGF2 Axis Confers Aggressiveness in Lethal Prostate Cancer
- (2015) Samuel J. Vidal et al. CANCER CELL
- Clinical Pharmacokinetic Studies of Enzalutamide
- (2015) Jacqueline A. Gibbons et al. CLINICAL PHARMACOKINETICS
- Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers
- (2015) Xiaoyang Zhang et al. NATURE GENETICS
- The Mediator complex: a central integrator of transcription
- (2015) Benjamin L. Allen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Enzalutamide: Development from bench to bedside
- (2015) R.M. Bambury et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer
- (2015) Zhong Chen et al. Nature Communications
- Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer
- (2014) Z. Chen et al. EMBO JOURNAL
- Enzalutamide versus abiraterone acetate for the treatment of men with metastatic castration-resistant prostate cancer
- (2014) Tian Zhang et al. EXPERT OPINION ON PHARMACOTHERAPY
- Reconstitution of active human core Mediator complex reveals a critical role of the MED14 subunit
- (2014) Murat A Cevher et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer
- (2014) Dayong Wu et al. NUCLEIC ACIDS RESEARCH
- GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex
- (2014) Bin He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer
- (2014) Masis Isikbay et al. Hormones & Cancer
- Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
- (2013) Vivek K. Arora et al. CELL
- Modification of Enhancer Chromatin: What, How, and Why?
- (2013) Eliezer Calo et al. MOLECULAR CELL
- Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis
- (2013) X Yuan et al. ONCOGENE
- Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator
- (2013) I. Zalachoras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting the androgen receptor in the management of castrationresistant prostate cancer: rationale, progress, and future directions
- (2012) R. Leibowitz–Amit et al. Current Oncology
- Allosteric Modulators of Steroid Hormone Receptors: Structural Dynamics and Gene Regulation
- (2012) Raj Kumar et al. ENDOCRINE REVIEWS
- Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer
- (2011) Biswajyoti Sahu et al. EMBO JOURNAL
- Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA
- (2011) Dong Wang et al. NATURE
- Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer
- (2010) Karen E. Knudsen et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
- (2009) Qianben Wang et al. CELL
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/β-catenin pathway
- (2008) R-S Chen et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started